• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探究人肌肽酶 I(CN1)和 II(CN2)之间的结构和动力学差异。

Exploring the structural and dynamic differences between human carnosinase I (CN1) and II (CN2).

机构信息

Department of Chemistry, Faculty of Science, Kasetsart University, Bangkok, Thailand.

Department of Computer Engineering, Faculty of Engineering, Kasetsart University, Bangkok, Thailand.

出版信息

Proteins. 2023 Jun;91(6):822-830. doi: 10.1002/prot.26469. Epub 2023 Jan 24.

DOI:10.1002/prot.26469
PMID:36637795
Abstract

Human carnosinases (CNs) are dimeric dipeptidases in the metallopeptidase M20 family. Two isoforms of carnosinases (Zn -containing carnosinase 1 (CN1) found in serum and Mn -carnosinase 2 (CN2) in tissue) were identified. Both CNs cleave histidine-containing (Xaa-His) dipeptides such as carnosine where CN2 was found to accept a broader spectrum of substrates. A loss of CN function, resulting in a high carnosine concentration, reduces risk for diabetes and neurological disorders. Although several studies on CN activities and its Michaelis complex were conducted, all shed the light on CN1 activity where the CN2 data is limited. Also, the molecular details on CN1 and CN2 similarity and dissimilarity in structure and function remain unclear. Thus, in this work, molecular dynamics (MD) simulations were employed to study structure and dynamics of human CN1 and CN2 in comparison. The results show that the different catalytic ability of both CNs is due to their pocket size and environment. CN2 can accept a wider range of substrate due to the wider mouth of a binding pocket. The L1 loop seems to play a role in gating activity. Comparing to CN2, CN1 provides more electronegative entrance, more wettability, and higher stability of catalytic metal ion-pair in the active site which allow more efficient water-mediated catalysis. The microscopic understanding obtained here can serve as a basis for CN inhibition strategies resulting in higher carnosine levels and consequently mitigating complications associated with diseases such as diabetes and neurological disorder.

摘要

人肌肽酶(CNs)是金属肽酶 M20 家族中的二聚二肽酶。已经鉴定出两种肌肽酶同工型(血清中含 Zn 的肌肽酶 1(CN1)和组织中的 Mn-肌肽酶 2(CN2))。两种 CN 都能切割含组氨酸的(Xaa-His)二肽,如肌肽,其中 CN2 被发现能接受更广泛的底物谱。CN 功能丧失导致肌肽浓度升高,从而降低了患糖尿病和神经紊乱的风险。尽管已经进行了几项关于 CN 活性及其 Michaelis 复合物的研究,但所有这些研究都集中在 CN1 活性上,而对 CN2 的研究数据有限。此外,关于 CN1 和 CN2 在结构和功能上的相似性和差异性的分子细节仍不清楚。因此,在这项工作中,采用分子动力学(MD)模拟来比较研究人 CN1 和 CN2 的结构和动力学。结果表明,两种 CN 的不同催化能力归因于它们结合口袋的大小和环境。由于结合口袋的开口较宽,CN2 可以接受更广泛的底物范围。L1 环似乎在门控活性中发挥作用。与 CN2 相比,CN1 在活性位点提供了更多的带负电荷的入口、更高的亲水性和催化金属离子对的更高稳定性,这允许更有效的水介导催化。这里获得的微观理解可以作为 CN 抑制策略的基础,从而提高肌肽水平,进而减轻与糖尿病和神经紊乱等疾病相关的并发症。

相似文献

1
Exploring the structural and dynamic differences between human carnosinase I (CN1) and II (CN2).探究人肌肽酶 I(CN1)和 II(CN2)之间的结构和动力学差异。
Proteins. 2023 Jun;91(6):822-830. doi: 10.1002/prot.26469. Epub 2023 Jan 24.
2
Mechanistic insights on anserine hydrolyzing activities of human carnosinases.关于人肌肽酶鹅肌肽水解活性的机制性见解。
Biochim Biophys Acta Gen Subj. 2023 Mar;1867(3):130290. doi: 10.1016/j.bbagen.2022.130290. Epub 2022 Dec 16.
3
Carnosinases, their substrates and diseases.肌肽酶、其底物与疾病
Molecules. 2014 Feb 21;19(2):2299-329. doi: 10.3390/molecules19022299.
4
Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase.人肌肽酶及一种密切相关的非特异性二肽酶的序列鉴定与特性分析
J Biol Chem. 2003 Feb 21;278(8):6521-31. doi: 10.1074/jbc.M209764200. Epub 2002 Dec 6.
5
The zinc form of carnosine dipeptidase 2 (CN2) has dipeptidase activity but its substrate specificity is different from that of the manganese form.肌肽二肽酶2(CN2)的锌形式具有二肽酶活性,但其底物特异性与锰形式不同。
Biochem Biophys Res Commun. 2017 Dec 16;494(3-4):484-490. doi: 10.1016/j.bbrc.2017.10.100. Epub 2017 Oct 19.
6
Carnosine and Homocarnosine Degradation Mechanisms by the Human Carnosinase Enzyme CN1: Insights from Multiscale Simulations.人肌肽酶CN1对肌肽和高肌肽的降解机制:多尺度模拟的见解
Biochemistry. 2016 May 17;55(19):2772-84. doi: 10.1021/acs.biochem.5b01263. Epub 2016 May 4.
7
Structural basis for substrate recognition and hydrolysis by mouse carnosinase CN2.小鼠肌肽酶CN2对底物识别和水解的结构基础。
J Biol Chem. 2008 Oct 3;283(40):27289-99. doi: 10.1074/jbc.M801657200. Epub 2008 Jun 12.
8
Carnosine metabolism in diabetes is altered by reactive metabolites.糖尿病中肌肽代谢会因反应性代谢产物而改变。
Amino Acids. 2015 Nov;47(11):2367-76. doi: 10.1007/s00726-015-2024-z. Epub 2015 Jun 17.
9
Carnosinase, diabetes mellitus and the potential relevance of carnosinase deficiency.肉毒碱酶、糖尿病和肉毒碱酶缺乏的潜在相关性。
J Inherit Metab Dis. 2018 Jan;41(1):39-47. doi: 10.1007/s10545-017-0099-2. Epub 2017 Oct 13.
10
Synthesis of functional dipeptide carnosine from nonprotected amino acids using carnosinase-displaying yeast cells.利用展示有肌肽酶的酵母细胞从非保护氨基酸合成功能性二肽肌肽。
Appl Microbiol Biotechnol. 2010 May;86(6):1895-902. doi: 10.1007/s00253-009-2396-7. Epub 2010 Jan 15.

引用本文的文献

1
Why Bestatin Prefers Human Carnosinase 2 (CN2) to Human Carnosinase 1 (CN1).为什么贝司他汀对人肌肽酶2(CN2)的偏好高于人肌肽酶1(CN1)。
J Phys Chem B. 2024 Dec 5;128(48):11876-11884. doi: 10.1021/acs.jpcb.4c05571. Epub 2024 Nov 22.
2
State of the Art in the Development of Human Serum Carnosinase Inhibitors.人血清瓜氨酸酶抑制剂研发的最新进展。
Molecules. 2024 May 24;29(11):2488. doi: 10.3390/molecules29112488.
3
Binding Modes of Carnostatine, Homocarnosine, and Ophidine to Human Carnosinase 1.肌肽抑制素、高肌肽和蛇肌肽与人肌肽酶1的结合模式
ACS Omega. 2023 Nov 2;8(45):42966-42975. doi: 10.1021/acsomega.3c06139. eCollection 2023 Nov 14.